Fenimore Christopher R.

US insider· US
Sign in for alerts
  • ACQUIREDStale

    Regeneron Pharmaceuticals · NASDAQ

    +6,283 sh · $2.4M

    Filed 20 Aug 2026SEC Form 4view source
  • REDUCEDStale

    Regeneron Pharmaceuticals · NASDAQ

    −4,599 sh · $3.7M

    Filed 20 Aug 2026SEC Form 4view source